E-LIB Suche - Ergebnisse für: Guris, Dalya

1

Safety and immunogenicity of intramuscular, single-dose V59..:

Robbins, Jonathan A. ; Tait, Dereck ; Huang, Qinlei...
eBioMedicine. 82 (2022) - p. 104138 , 2022

Link: https://doi.org/10.1016/..

2

Demonstration of durable hepatitis B immune memory in child..:

Ahonen, Anitta ; Zhang, Ying ; Marček, Tomáš...
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

3

In RRP, serologic response to HPV is frequently absent and ..:

Buchinsky, Farrel J. ; Ruszkay, Nicole ; Valentino, William...
PLOS ONE. 15 (2020) 3 - p. e0230106 , 2020

Link: https://doi.org/10.1371/..

4

Bezlotoxumab for prevention of Clostridium difficile infect..:

Zeng, Zhen ; Zhao, Hailong ; Dorr, Mary Beth...
Anaerobe. 61 (2020) - p. 102137 , 2020

Link: https://doi.org/10.1016/..

5

Influence of Diagnostic Method on Outcomes in Phase 3 Clini..:

Wilcox, Mark H ; Rahav, Galia ; Dubberke, Erik R...
Open Forum Infectious Diseases. 6 (2019) 8 - p. , 2019

Link: https://doi.org/10.1093/..

6

Effect of Endogenous Clostridioides difficile Toxin Antibod..:

Dorr, Mary Beth ; Guris, Dalya ; Railkar, Radha...
Clinical Infectious Diseases. 71 (2019) 1 - p. 81-86 , 2019

Link: https://doi.org/10.1093/..

7

Efficacy of bezlotoxumab based on timing of administration ..:

Birch, Thomas ; Golan, Yoav ; Rizzardini, Giuliano...
Journal of Antimicrobial Chemotherapy. 73 (2018) 9 - p. 2524-2528 , 2018

Link: https://doi.org/10.1093/..

8

Bezlotoxumab for Prevention of Recurrent Clostridium diffic..:

Gerding, Dale N ; Kelly, Ciaran P ; Rahav, Galia...
Clinical Infectious Diseases. 67 (2018) 5 - p. 649-656 , 2018

Link: https://doi.org/10.1093/..

9

Primary Outcomes From a Phase 3, Randomized, Double-Blind, ..:

Boix, Vicente ; Fedorak, Richard N. ; Mullane, Kathleen M....
Open Forum Infectious Diseases. 4 (2017) 1 - p. , 2017

Link: https://doi.org/10.1093/..

10

Endogenous Serum IgG Antibodies to Clostridium difficile To..:

Kelly, Ciaran P ; Poxton, Ian R ; Shen, Judong...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S388-S388 , 2017

Link: https://doi.org/10.1093/..

11

Efficacy of Bezlotoxumab in Patients with Recurrent Clostri..:

Yacyshyn, Bruce ; Rahav, Galia ; Kao, Dina H....
Gastroenterology. 152 (2017) 5 - p. S343 , 2017

Link: https://doi.org/10.1016/..

12

Bezlotoxumab (BEZ) for Prevention of Clostridium difficile ..:

Dorr, Mary Beth ; Zeng, Zhen ; Wilcox, Mark...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S388-S389 , 2017

Link: https://doi.org/10.1093/..

13

Antibodies to Toxin B Are Protective AgainstClostridium dif..:

Gupta, Swati B. ; Mehta, Vinay ; Dubberke, Erik R....
Clinical Infectious Diseases. 63 (2016) 6 - p. 730-734 , 2016

Link: https://doi.org/10.1093/..

14

Antibodies to Toxin B Are Protective Against Clostridium di..:

Gupta, Swati B. ; Mehta, Vinay ; Dubberke, Erik R....
Clinical Infectious Diseases. 63 (2016) 6 - p. 730-734 , 2016

Link: https://www.jstor.org/st..

15

Efficacy of Bezlotoxumab in Patients Receiving Metronidazol..:

Dubberke, Erik R. ; Gerding, Dale ; Kelly, Ciaran...
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..